CHC Healthcare Group Future Growth
Future criteria checks 4/6
CHC Healthcare Group is forecast to grow earnings and revenue by 68.3% and 15.5% per annum respectively while EPS is expected to grow by 68.2% per annum.
Key information
68.3%
Earnings growth rate
68.2%
EPS growth rate
Healthcare earnings growth | 19.0% |
Revenue growth rate | 15.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Oct 2024 |
Recent future growth updates
Recent updates
CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2
Jun 29CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01
Jun 15If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%
Mar 08CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 07Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?
Jan 21Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?
Jan 06Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?
Dec 22CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years
Dec 07Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 4,620 | 513 | N/A | N/A | 1 |
12/31/2024 | 3,575 | 124 | 561 | 1,061 | 1 |
9/30/2024 | 4,032 | 324 | 22 | 462 | N/A |
6/30/2024 | 3,807 | 274 | 416 | 863 | N/A |
3/31/2024 | 3,734 | 342 | 580 | 1,232 | N/A |
12/31/2023 | 3,877 | 419 | 387 | 963 | N/A |
9/30/2023 | 3,283 | 302 | -120 | 480 | N/A |
6/30/2023 | 3,362 | 360 | -148 | 534 | N/A |
3/31/2023 | 3,168 | 376 | -331 | 321 | N/A |
12/31/2022 | 2,974 | 357 | -26 | 657 | N/A |
9/30/2022 | 2,992 | 409 | 197 | 873 | N/A |
6/30/2022 | 2,654 | 375 | 62 | 676 | N/A |
3/31/2022 | 2,405 | 337 | 124 | 717 | N/A |
12/31/2021 | 2,440 | 382 | 179 | 693 | N/A |
9/30/2021 | 2,098 | 294 | 43 | 795 | N/A |
6/30/2021 | 2,451 | 383 | 177 | 913 | N/A |
3/31/2021 | 2,641 | 400 | 280 | 898 | N/A |
12/31/2020 | 2,555 | 366 | 195 | 916 | N/A |
9/30/2020 | 2,630 | 396 | 747 | 1,245 | N/A |
6/30/2020 | 2,741 | 393 | 836 | 1,245 | N/A |
3/31/2020 | 2,875 | 407 | 1,015 | 1,401 | N/A |
12/31/2019 | 2,950 | 395 | 871 | 1,215 | N/A |
9/30/2019 | 3,003 | 402 | 121 | 444 | N/A |
6/30/2019 | 2,791 | 347 | 39 | 357 | N/A |
3/31/2019 | 2,733 | 366 | -296 | 147 | N/A |
12/31/2018 | 2,507 | 323 | -33 | 338 | N/A |
9/30/2018 | 2,463 | 37 | 33 | 391 | N/A |
6/30/2018 | 2,193 | -39 | N/A | 454 | N/A |
3/31/2018 | 1,948 | -142 | N/A | 420 | N/A |
12/31/2017 | 2,117 | -87 | N/A | 294 | N/A |
9/30/2017 | 2,307 | 240 | N/A | 512 | N/A |
6/30/2017 | 2,242 | 232 | N/A | 445 | N/A |
3/31/2017 | 2,418 | 227 | N/A | 735 | N/A |
12/31/2016 | 2,205 | 159 | N/A | 845 | N/A |
9/30/2016 | 2,165 | 133 | N/A | 628 | N/A |
6/30/2016 | 2,366 | 185 | N/A | 786 | N/A |
3/31/2016 | 2,450 | 271 | N/A | 782 | N/A |
12/31/2015 | 2,395 | 227 | N/A | 576 | N/A |
9/30/2015 | 2,363 | 236 | N/A | 732 | N/A |
6/30/2015 | 2,176 | 205 | N/A | 612 | N/A |
3/31/2015 | 1,974 | 189 | N/A | 436 | N/A |
12/31/2014 | 2,091 | 266 | N/A | 634 | N/A |
9/30/2014 | 2,000 | 242 | N/A | 738 | N/A |
6/30/2014 | 2,240 | 326 | N/A | 596 | N/A |
3/31/2014 | 2,117 | 328 | N/A | 673 | N/A |
12/31/2013 | 2,063 | 297 | N/A | 867 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4164's forecast earnings growth (68.3% per year) is above the savings rate (1.1%).
Earnings vs Market: 4164's earnings (68.3% per year) are forecast to grow faster than the TW market (19.4% per year).
High Growth Earnings: 4164's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4164's revenue (15.5% per year) is forecast to grow faster than the TW market (12.7% per year).
High Growth Revenue: 4164's revenue (15.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4164's Return on Equity is forecast to be high in 3 years time